- Home
- INM vs EVOK Comparison
INM vs EVOK Comparison
Compare INM & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- EVOK
- Stock Information
- Founded
- INM 1981
- EVOK 2007
- Country
- INM Canada
- EVOK United States
- Employees
- INM N/A
- EVOK N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- EVOK Health Care
- Exchange
- INM Nasdaq
- EVOK Nasdaq
- Market Cap
- INM 5.0M
- EVOK 5.4M
- IPO Year
- INM N/A
- EVOK 2013
- Fundamental
- Price
- INM $2.07
- EVOK $4.75
- Analyst Decision
- INM
- EVOK
- Analyst Count
- INM 0
- EVOK 0
- Target Price
- INM N/A
- EVOK N/A
- AVG Volume (30 Days)
- INM 116.2K
- EVOK 26.9K
- Earning Date
- INM 11-13-2025
- EVOK 11-07-2025
- Dividend Yield
- INM N/A
- EVOK N/A
- EPS Growth
- INM N/A
- EVOK N/A
- EPS
- INM N/A
- EVOK N/A
- Revenue
- INM $4,942,633.00
- EVOK $12,794,859.00
- Revenue This Year
- INM N/A
- EVOK $57.38
- Revenue Next Year
- INM N/A
- EVOK $59.57
- P/E Ratio
- INM N/A
- EVOK N/A
- Revenue Growth
- INM 7.50
- EVOK 70.02
- 52 Week Low
- INM $1.72
- EVOK $1.94
- 52 Week High
- INM $8.27
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- INM 42.37
- EVOK 49.18
- Support Level
- INM $2.04
- EVOK $4.53
- Resistance Level
- INM $2.26
- EVOK $4.69
- Average True Range (ATR)
- INM 0.14
- EVOK 0.25
- MACD
- INM -0.01
- EVOK 0.02
- Stochastic Oscillator
- INM 10.44
- EVOK 74.98
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.